Literature DB >> 19142032

Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration.

Kazim Husain1, Rony A Francois, Sean Z Hutchinson, Anthony M Neuger, Richard Lush, Domenico Coppola, Said Sebti, Mokenge P Malafa.   

Abstract

Tocotrienols are natural vitamin E compounds that are known to have a neuroprotective effect at nanomolar concentration and anti-carcinogenic effect at micromolar concentration. In this report, we investigated the pharmacokinetics, tumor and pancreatic tissue levels, and toxicity of delta-tocotrienol in mice because of its anti-tumor activity against pancreatic cancer. Following a single oral administration of delta-tocotrienol at 100 mg/kg, the peak plasma concentration (C(max)) was 57 +/- 5 micromol/l, the time required to reach peak plasma concentration (T(max)) was 2 h and plasma half-life (t(1/2)) was 3.5 h. The delta-tocotrienol was cleared from plasma and liver within 24 h, but delayed from the pancreas. When mice were fed delta-tocotrienol for 6 weeks, the concentration in tumor tissue was 41 +/- 3.5 nmol/g. This concentration was observed with the oral dose (100 mg/kg) of delta-tocotrienol which inhibited tumor growth by 80% in our previous studies. Interestingly, delta-tocotrienol was 10-fold more concentrated in the pancreas than in the tumor. We observed no toxicity due to delta-tocotrienol as mice gained normal weight with no histopathological changes in tissues. Our data suggest that bioactive levels of delta-tocotrienol can be achieved in the pancreas following oral administration and supports its clinical investigation in pancreatic cancer. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142032      PMCID: PMC2834260          DOI: 10.1159/000190792

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  34 in total

1.  Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status.

Authors:  S P Yap; K H Yuen; J W Wong
Journal:  J Pharm Pharmacol       Date:  2001-01       Impact factor: 3.765

2.  Oral toxicity of a tocotrienol preparation in rats.

Authors:  H Nakamura; F Furukawa; A Nishikawa; M Miyauchi; H Y Son; T Imazawa; M Hirose
Journal:  Food Chem Toxicol       Date:  2001-08       Impact factor: 6.023

3.  Differential inhibition of hepatic, pancreatic, and plasma fatty acid ethyl ester synthase by tri-o-tolylphosphate in rats.

Authors:  Kelly A Mericle; Bhupendra S Kaphalia; G A S Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2002-03-01       Impact factor: 4.219

4.  Dietary sesame seeds elevate alpha- and gamma-tocotrienol concentrations in skin and adipose tissue of rats fed the tocotrienol-rich fraction extracted from palm oil.

Authors:  S Ikeda; K Toyoshima; K Yamashita
Journal:  J Nutr       Date:  2001-11       Impact factor: 4.798

5.  Simple high-performance liquid chromatographic method for the determination of tocotrienols in human plasma.

Authors:  S P Yap; T Julianto; J W Wong; K H Yuen
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-12-10

6.  The lipids of mammalian pancreas.

Authors:  C Prottey; J N Hawthorne
Journal:  Biochem J       Date:  1966-10       Impact factor: 3.857

7.  Simultaneous determination of vitamin E homologs in chicken meat by liquid chromatography with fluorescence detection.

Authors:  A K Hewavitharana; M C Lanari; C Becu
Journal:  J Chromatogr A       Date:  2004-02-06       Impact factor: 4.759

8.  Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals.

Authors:  Gianfranco Panfili; Alessandra Fratianni; Mario Irano
Journal:  J Agric Food Chem       Date:  2003-07-02       Impact factor: 5.279

9.  Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects.

Authors:  Yasukazu Yoshida; Etsuo Niki; Noriko Noguchi
Journal:  Chem Phys Lipids       Date:  2003-03       Impact factor: 3.329

10.  Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones.

Authors:  M Podda; C Weber; M G Traber; L Packer
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

View more
  21 in total

1.  {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Vivek R Yadav; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

Review 2.  Tocotrienols: the lesser known form of natural vitamin E.

Authors:  Viren Patel; Cameron Rink; Savita Khanna; Chandan K Sen
Journal:  Indian J Exp Biol       Date:  2011-10       Impact factor: 0.818

3.  Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites.

Authors:  Amit Mahipal; Jason Klapman; Shivakumar Vignesh; Chung S Yang; Anthony Neuger; Dung-Tsa Chen; Mokenge P Malafa
Journal:  Cancer Chemother Pharmacol       Date:  2016-06-08       Impact factor: 3.333

Review 4.  Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy.

Authors:  Qing Jiang
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

5.  Vitamin E forms inhibit IL-13/STAT6-induced eotaxin-3 secretion by up-regulation of PAR4, an endogenous inhibitor of atypical PKC in human lung epithelial cells.

Authors:  Yun Wang; Michelle Moreland; James G Wagner; Bruce N Ames; Beate Illek; David B Peden; Qing Jiang
Journal:  J Nutr Biochem       Date:  2011-07-20       Impact factor: 6.048

6.  Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients.

Authors:  Viren Patel; Cameron Rink; Gayle M Gordillo; Savita Khanna; Urmila Gnyawali; Sashwati Roy; Bassel Shneker; Kasturi Ganesh; Gary Phillips; J Layne More; Atom Sarkar; Robert Kirkpatrick; Elmahdi A Elkhammas; Emily Klatte; Michael Miller; Michael S Firstenberg; E Antonio Chiocca; Kalanithi Nesaretnam; Chandan K Sen
Journal:  J Nutr       Date:  2012-02-01       Impact factor: 4.798

7.  Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer.

Authors:  Kazim Husain; Rony A Francois; Teruo Yamauchi; Marta Perez; Said M Sebti; Mokenge P Malafa
Journal:  Mol Cancer Ther       Date:  2011-10-04       Impact factor: 6.261

8.  Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.

Authors:  Kazim Husain; Barbara A Centeno; Dung-Tsa Chen; Sunil R Hingorani; Said M Sebti; Mokenge P Malafa
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-20

Review 9.  Potential Role of Tocotrienols on Non-Communicable Diseases: A Review of Current Evidence.

Authors:  Sok Kuan Wong; Yusof Kamisah; Norazlina Mohamed; Norliza Muhammad; Norliana Masbah; Nur Azlina Mohd Fahami; Isa Naina Mohamed; Ahmad Nazun Shuid; Qodriyah Mohd Saad; Azman Abdullah; Nur-Vaizura Mohamad; Nurul' Izzah Ibrahim; Kok-Lun Pang; Yoke Yue Chow; Benjamin Ka Seng Thong; Shaanthana Subramaniam; Chin Yi Chan; Soelaiman Ima-Nirwana; And Kok-Yong Chin
Journal:  Nutrients       Date:  2020-01-19       Impact factor: 5.717

Review 10.  Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.

Authors:  Ashley H Davis-Yadley; Mokenge P Malafa
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.